imexpharm announces third quarter results

Imexpharm announces third quarter results

On October 18, Imexpharm Corporation announced its third quarter results for the three months ending September 30, 2024.
imexpharms ambitions to enter global pharma supply chain

Imexpharm’s ambitions to enter global pharma supply chain

Imexpharm is driving significant growth by boosting research and development (R&D) into high-tech pharmaceuticals.
imexpharm part of emerging trend of innovation in pharmaceuticals

Imexpharm part of emerging trend of innovation in pharmaceuticals

Imexpharm Pharmaceutical JSC (IMP) is investing heavily in high-quality pharmaceutical production technology to meet international standards.
imexpharm recognised at top 50 corporate sustainability awards

Imexpharm recognised at Top 50 Corporate Sustainability Awards

Imexpharm Pharmaceutical JSC was honoured at the Top 50 Corporate Sustainability Awards (CSA 2023) organised by Nhip Cau Dau Tu magazine on August 2.
imexpharm announces interim results for h1

Imexpharm announces interim results for H1

Imexpharm Corporation (IMP.VN), a pioneering leader in Vietnam’s pharmaceutical industry, has announced its interim results for H1.
imexpharm and deloitte vietnam launch flagship project on resource management

Imexpharm and Deloitte Vietnam launch flagship project on resource management

Imexpharm Pharmaceuticals JSC and Deloitte Vietnam celebrated the launch of a project to upgrade its enterprise resource planning system leveraging flagship SAP S/4HANA solution on July 3 at Imexpharm's headquarters in Dong Thap province.
imexpharm honoured with vietnam pharmaceutical star award

Imexpharm honoured with Vietnam Pharmaceutical Star award

Imexpharm Pharmaceutical JSC proudly received the “Vietnam Pharmaceutical Star” award on May 17.
imexpharm welcomes shareholders analysts and potential investors at agm

Imexpharm welcomes shareholders, analysts and potential investors at AGM

Imexpharm Corporation (Imexpharm), a pioneering leader in Vietnam’s pharmaceutical industry, held its AGM at the Hilton Saigon Hotel on April 26.
outlook for pharmaceutical stocks in 2024

Outlook for pharmaceutical stocks in 2024

At a macro level in which there is still complexity, the pharmaceutical industry is expected to continue witnessing positive business results in 2024.
imexpharm set growth record in 2023

Imexpharm set growth record in 2023

Imexpharm Corporation (Imexpharm or IMP.VN), a pioneer in Vietnam’s pharmaceutical industry, announced its business results on March 27, for the fiscal year ending December 31, 2023.
imexpharm joins vietnams campaign to plant one billion trees

Imexpharm joins Vietnam's campaign to plant one billion trees

Imexpharm Pharmaceutical JSC (IMP) teamed up with Nha Trang People's Committee to plant 500 trees along Ring Road 2 on March 18.
imexpharm forges partnership with genuone sciences

Imexpharm forges partnership with Genuone Sciences

On February 23, Imexpharm JSC (IMP) officially announced the signing of a strategic cooperation agreement with Genuone Sciences Inc., one of the leading pharmaceutical companies from South Korea.
imexpharm opens new representative office in ho chi minh city

Imexpharm opens new representative office in Ho Chi Minh City

Imexpharm has opened a new office to grasp fresh opportunities for growth after a period of in-depth investment in modern production technologies.
domestic pharmaceutical products anticipate 2024 boost

Domestic pharmaceutical products anticipate 2024 boost

2023 witnessed many fluctuations in the economy, with various industrial fields witnessing negative growth, but the pharmaceutical industry remains growing thanks to the breakthroughs of leading pharmaceutical companies.
imexpharm clinches top honours in corporate annual reporting

Imexpharm clinches top honours in corporate annual reporting

Imexpharm, outstripping its 2023 financial targets, underscores its ascent with top honours in corporate governance, affirming its stature in Vietnam's pharmaceutical sector.